February 15, 2008 -- Tianyin Pharma (OTCBB: VSCO) announced that it made a profit of $3.2 million on $14.9 million in revenue during the first six months of its fiscal 2008. Revenues were up 70% during the period, while net income increased 65%. The company said its growth was due to new distribution partners and a larger sales force. Although the numbers were up substantially year over year, 1st quarter and 2nd quarter figures were almost identical, making it seem as though the growth has stalled. More details...
